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Abstract
Background Several studies indicate that increasing the ali-
mentary limb length in gastric bypass surgery produces only a
minor improvement of excess BMI loss. Few studies have
addressed the efficacy of increasing the length of the
pancreatico-biliary limb.
Methods Here, we present a prospective randomized study of
187 consecutive laparoscopic Roux-Y gastric bypass opera-
tions operated over 2 years (2004–2005) in Iceland. The
patients were operated with a gastric bypass with either a 2-
m biliopancreatic (BP)-limb and a 60-cm alimentary (A)-limb
(n=93) or with a 150-cm A-limb and a 60-cm BP-limb (n=
94).
Results Preoperative median BMI was 44.1 (38–70), median
age 35.5 (17–74) years, and 85 % of the patients were female.
Follow-up rate after 5 years was 85 %. Eighteen months
following surgery, the weight loss was significantly higher
in the BP-limb group (p<0.001), and this difference remained
7 years after surgery. Weight regain occurred in both groups,
and 7 years after surgery, excess BMI loss (EBMIL) was
78.4 % in the BP-limb group compared to 67.1 % in the A-
limb group (p<0.001). Most patients (78 %) needed supple-
mentation adjustment (iron, vitamin D and calcium) during
the study period, significantly more often in the BP-limb
group compared to the A-limb group (p<0.001). Patients in
the BP-limb group had more frequent stools than patients in
the A-limb group; otherwise, gastro-intestinal symptoms rat-
ing scoring were comparable. Complication rate was similar.
Conclusions Gastric bypass with a 2-m BP-limb gives better
weight loss than gastric bypass with a 60-cm BP-limb and a
150-cmA-limb. Metabolic follow-up is of utmost importance,
as most patients needed repeated adjustments of their
supplementation.
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Introduction
Mason and Ito introduced gastric bypass (Roux-en-Y gastric
bypass (RYGBP)) in the late 1960s, but still, there is no
consensus on the ideal length of the gastric bypass limb
lengths [1]. The operation results in excess weight loss
(EWL) of 70–80 % after 1 to 2 years with high resolution of
co-morbidities, but some patients regain significant weight,
especially super obese patients. In order to improve results and
to find the appropriate balance between benefits and side
effects and metabolic sequels, studies with different limb
lengths have been performed.
Many studies have been performed with variable lengths of
the Roux limb (alimentary (A)-limb), ranging from 45 to
250 cm; they show no or marginal difference in the effect on
weight loss. Four of them are randomized studies [2–5], but
most are retrospective comparisons [6–10]. Most of these
studies are of small volume and not showing data beyond
5 years.
Many authors have demonstrated that weight loss after
bariatric surgery and resolution of co-morbidities are strongly
associated with a short common channel [11–15], but the
shorter the common channel, the more malabsorption and
metabolic problems can be expected [7, 12, 14].
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However, it should also be noted that no reference can be
made to the effect of the ratio of the Roux to the
biliopancreatic (BP)-limbs on weight loss and co-morbidity
resolution outcomes as there is no available literature that has
investigated this issue [16]. Furthermore, long-term weight
loss data (>5 years) are not available from randomized con-
trolled trials and are extremely limited in studies of other
design [16]. Nevertheless, most authors believe that this ratio
is unlikely to have any significant impact on outcome com-
pared to the ratio of the Roux/BP to the common channel
length.
The aim of this study was to compare the effect of the
RYGBP with a 200-cm BP-limb (long BP) to a more com-
monly performed RYGBP with a 150-cm long alimentary
limb (150-cm A-limb) and a 60-cm BP-limb (long A)
(Fig. 1). The long-term effects on weight loss, resolution of
co-morbidities, gastro-intestinal symptoms, metabolic param-
eters and complications were examined.
Materials and Methods
Patients
Prior to this study, our standard laparoscopic gastric bypass
procedure was Roux-en-Y gastric bypass with gastric pouch
approximately 40 ml, biliopancreatic limb (BP-limb) of
200 cm and alimentary limb (A-limb) of 50 cm [17]. With
this procedure, we had a problem with a high incidence of
marginal ulcers (16.6 % of patients) [17]. Six (comment 1,
reviewer 2) months before the study starts, we changed our
procedure to a RYGBP with a gastric pouch of approximately
15 ml, BP-limb of 200 cm and A-limb of 60 cm.
Between January 2004 and December 2005, all 187 mor-
bidly obese patients who underwent primary RYGBP at our
institution were included in the study. The same surgical team
(HG, BGL) performed all operations. The patient selection
criteria were BMI > 40 or BMI > 35 with associated co-
morbidity due to obesity (European Guidelines). Prior to
surgery, patients participated in a multidisciplinary outpa-
tients’ preparation program, as described in detail earlier
[17], and contracted to follow our follow-up program. A
protocol was designed at the outset of the study for random
allocation of the patients to either of the two arms. The
surgical arms are illustrated in Fig. 1. Postoperatively, patients
were instructed to take standard supplementation of vitamins
and minerals including multivitamin, calcium citrate, vitamin
B-12 and vitamin D. Patients were followed up at the outpa-
tient clinic with weight registration and metabolic surveil-
lance, first after 3 months and then every 6 months for 3 years,
then once a year.
Resolution of diabetes type 2 was defined as patient with-
out diabetic medication and with glycosylated haemoglobin
(HbA1c) within the normal range. Resolution of hypertension
was defined as patient without treatment having blood pres-
sure less than 140/90. Patients using continuous positive
airway pressure (CPAP) were considered to have sleep
apnoea.
Six to 7 years after surgery, patients received a standardized
questionnaire including gastro-intestinal symptom rating scale
(GSRS). It is an interview-based rating scale consisting of 15
items, originally constructed for the assessment of gastro-
intestinal symptoms in the irritable bowel syndrome and
Fig. 1 Schematic drawing of the operation with 150-cm A-limb or 200-cm BP-limb
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peptic ulcer disease [18–21]. For the GSRS, the following five
dimensions were used in this study: abdominal pain syndrome
(three items), reflux syndrome (two items), indigestion syn-
drome (four items), diarrhoea syndrome (three items), and
constipation syndrome (three items).
This studywas approved by the institutional review board and
the Icelandic scientific ethical committee VSNa2001050041.
Statistics
Data from all the patients during the study period were pro-
spectively collected in a proprietary database as part of the
hospital records. Proportions are referred to as numbers (%).
Continuous data are presented as median and range unless
otherwise stated. Differences between proportions were eval-
uated using Fisher’s exact test. Median differences between
groups were evaluated using the Mann-Whitney U test.
Comparison of mean percentage excess BMI loss
(EBMIL%) between groups was done using Student’s t test.
A p value <0.05 was regarded as statistically significant.
Weight loss was expressed as percentage excess BMI loss
(EBMIL%) plotted against time from operation. The lines
were drawn using the locally weighted scatter plot smoothing
method (Lowess). All statistical computations were performed
using the SPSS version 21.0 forMacOS (SPSS Inc., Chicago).
Surgical Procedure
Five ports were used: two 5-mm and two 12-mm ports for
instruments and one 10-mm port for the camera. A small
gastric pouch (15 ml) was created with a 3.5-mm stapler
(Endo-GIA II, Tyco/US Surgical). The greater omentum was
then split vertically to allow a tension-free antecolic gastro-
jejunal anastomosis (GJ anastomosis). The ligament of Treitz
Table 1 Patient demographics







Age (years) 34 (17–74) 37 (22–61) 0.383
Gender, F/M 79/15 (84 %) 81/12 (87 %) 0.678
BMI 44.5 (39–70) 43.7 (38–68) 0.595
Super obese (BMI > 50) 35 (37.2 %) 31 (33.3 %) 0.647
Weight (kg) 139 (115–225) 134 (92–215) 0.141
Fig. 2 Postoperative weight loss
expressed as percentage of excess
BMI loss (EBMIL%) plotted
against time. The lines are drawn
using the locally weighted scatter
plot smoothing method (Lowess).
The figures demonstrate a greater
weight loss using the long BP-
limb procedure compared to long
A-limb procedure
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was identified, and jejunum measured (loose, not stretched
using markers on the graspers) (comment 2, reviewer 2) 60 or
200 cm according to the group included (long A or long BP).
The bowel was brought up, first as an omega loop in an
antecolic and antegastric fashion, and the GJ anastomosis
was created by stapling the jejunum to the posterior wall of
the gastric pouch using a linear stapler (3.5-mm stapler). The
entero-entero anastomosis (EE anastomosis) was created as a
side-to-side anastomosis either 60 or 150 cm below the GJ
anastomosis using a 2.5-mm stapler. The remaining openings
were hand-sutured and the omega loop divided by the 2.5-mm
stapler. The last step was testing the integrity of the gastro-
jejunostomy by inflating it with methylene-blue-dyed saline
via an NG tube. The mesenteric defects were not closed. Our
surgical procedure at the time has previously been described
in detail in 2005 [17, 22].
Results
The results of 187 consecutive patients equally distributed (2–3
patients weekly) over a 2-year period (2004–2005) are present-
ed. Laparoscopic surgery was successfully completed in all
cases. Ninety-four patients were randomized to the BP-limb
group and 93 patients to the A-limb group. Patient’s character-
istics in the two groups are shown in Table 1.
A total of 85.6 % of patients (160/187) were females,
median age 35.5 (17–74). Before the start of the treatment,
median weight was 136.5 kg (92–225) and median BMI was
44.1 (38.3–70.3). Sixty-six (35.3%) patients were super obese
(BMI > 50). Mean weight loss prior to surgery was 12.7 kg
(0–46), similar in both groups. The median surgical time was
67.3 min (37–112), 68.3 min (40–112) in the BP-limb group
compared to 66.3 min (37–94) in the A-limb group (p=0.29)
(comment 9, reviewer 2). The median hospital stay was
2.9 days (2–10 days), 2.7 days (2–6) in the BP-limb group
and 3.1 days (1–10) in the A-limb group (p=0.30) (comment
9, reviewer 2). There was no difference between the two
groups (Table 1).
The diameter of small intestine just below the gastro-
intestinal anastomosis was measured in 20 patients in each
group with a soft plastic measuring tape (comment 3, re-
viewer 2). In the A-limb group, the median diameter was
3.5 cm (3.0–4.3) compared to 2.3 cm (1.9–3.1) in the BP-
limb group (p<0.05).
The median follow-up was 70.6 months (0.4–93), similar
in both groups. As shown in Fig. 2, 159 patients (85.0 %)
attended our outpatient clinic for follow-up of 5 years, and 110
Fig. 3 Postoperative weight loss
expressed as percentage of excess
BMI loss (EBMIL%) plotted
against time. The figures
demonstrate a greater weight loss
in both obese and super obese
patients using the long BP-limb
procedure compared to long A-
limb procedure
1598 OBES SURG (2014) 24:1595–1602
(59 %) completed follow-up 6 to 7 years after surgery.
Twenty-eight patients (15 %) had a follow-up of less than
5 years including three patients who died 1, 2 and 4 years after
surgery of unrelated causes.
Figure 2 shows the percentage excess BMI loss (EBMIL%)
in the two groups. For 18 months, weight loss was signifi-
cantly higher in the BP-limb group (p<0.001), and this dif-
ference remained throughout the study period. Mean excess
BMI loss reached a maximum of 88.5 % in the BP-limb group
2 years after surgery compared to 77.7 % in the A-limb group.
Weight regain occurred in both groups, and 7 years after
surgery, mean EBMIL was 78.4 % in the BP-limb group
compared to 67.1 % in the A-limb group. Weight loss failure
defined as EBMIL% never exceeding 50 % postoperatively
was only seen in four patients in the A-limb group compared
to none in the 2-m BP-limb group.
Figure 3 (upper part) shows the EBMIL% in those 110
study patients who were not super obese (BMI < 50). Seven
years after surgery, mean EBMIL was 82.2 % for the BP-limb
group compared to 69.2 % for the A-limb group (p<0.001).
Figure 3 (lower part) shows, however, EBMIL% in 66 preop-
eratively super obese patients (BMI > 50). Seven years after
surgery, mean EBMIL was 70.4 % in the BP-limb group
compared to 62.8 % in the A-limb group (p<0.01).
Early complications (<30 days) did not differ between the
two groups. Two patients had leaks (1.1%) treated by surgery;
five patients (2.7%) had bleedings, two treated by surgery and
three conservatively.
Late complications (>30 days) are shown in Table 2. Seven
to 9 years after gastric bypass, 15 patients (8 %) had surgery
due to internal hernia, 9 in the BP-limb group and 6 in the A-
limb group (p=0.592). Sixteen patients (8.6 %) had marginal
ulcers at the gastro-jejunal anastomosis treated conservatively,
eight in each group. Twenty-two patients (11.8 %) had surgery
due to gallbladder stones (preoperative ultrasound was not
performed) (comment 6, reviewer 2).
Co-morbidity was similar in both groups prior to surgery
(comment 9, reviewer 2). Table 3 shows the resolution of
obesity-related co-morbidities 5 to 9 years after gastric bypass.
A total of 20.9 % (39/187) were treated for diabetes type 2
Table 3 Preoperative incidence of obesity-related co-morbidities and the changes 5 to 9 years after Roux-en-y gastric bypass
A
All patients (n = 187) Study groups Preoperative incidence (%) Resolved (%) p Value
Diabetes type 2 39 (20.9 %) Long BP-limb (n = 94) 22 (23) 17 (77) 0.636
Long A-limb (n = 93) 17 (18) 12 (71)
Hypertension 59 (31.6 %) Long BP-limb (n = 94) 28 (30) 17 (61) 0.406
Long A-limb (n = 93) 31 (33) 22 (71)
Sleep apnoea 31 (17 %) Long BP-limb (n = 94) 19 (20) 17 (90) 0.245
Long A-limb (n = 93) 12 (13) 12 (100)
B
All patients (%) Long BP-limb (%) Long A-limb (%) p Value
GERD Worse 17 8 21
No change 4 % 0 10
Slightly improved 8 8 10
Much improved 8 0 17
Resolved 63 84 42 0.140
Joint pain Worse 19 25 16
No change 29 10 41
Slightly improved 15 25 9
Much improved 29 35 25
Resolved 8 5 9 0.136
Values given are number of patients and %; statistic calculated (Chi-square) in each group is based on no improvement versus improvement
Table 2 Late complications
(>30 days)









Internal hernia 15 (8 %) 9 (10 %) 6 (6 %) 0.592
Marginal ulcer 16 (8.6 %) 8 (9 %) 8 (9 %) 1.000
Gallbladder stones 22 (11.8 %) 13 (14 %) 9 (10 %) 0.497
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before surgery, 30with oral antidiabetic medication only and 9
with insulin (comment 7, reviewer 2). Five to 9 years after
surgery, 29 (74 %) had resolution of diabetes, no difference
between the two study groups. Fifty-nine patients (31 %) were
on treatment for hypertension; 39 patients (66 %) had resolu-
tion, no difference between the two surgical groups. Prior to
surgery, 19 patients had sleep apnoea using CPAP; after 5 to
9 years, 93 % (17/19) were not in need of CPAP. Thirteen
patients (6.9 %) had hyperlipidaemia prior to surgery; all of
them had a resolution 5 years or more after surgery (comment
10, reviewer 2). Before surgery, 37 patients (19.8 %) had
GERD (18 patients in the BP-limb and 19 in the A-limb
group) (comment 9, reviewer 2). Joint pain was recorded in
105 patients (56.1 %) prior to surgery (comment 10, reviewer
2). Dramatic improvement of GERD and joint pain was reg-
istered in most patients after surgery, similar in both study
groups (Table 3).
Table 4 shows the nutritional parameters in all patients
prior to surgery. A total of 35.5 % of the patients had nutri-
tional deficiency before surgery, most commonly vitamin D
deficiency (31 %). This was corrected postoperatively by
adding supplementation as needed in addition to the standard
supplementation.
Table 4 shows the percentage of patients in the two groups
needing adjustment of supplementation because of their
laboratory values being outside the reference values, three or
more years after surgery. Most patients (78 %) needed fre-
quent adjustment of their supplementation during the follow-
up period of 3 to 9 years. Need for adjustment of iron, vitamin
D and calcium citrate was significantly more common in the
BP-limb group compared to the A-limb group (p<0.001).
Only one patient (long BP) needed hospitalization due to
significant but reversible malnutrition problems caused by
serious eating disorder. Otherwise, nutrition problems were
solved at the outpatient clinic.
A total of 105 patients (56 %) answered the questionnaire.
The GSRS scores represented gastro-intestinal symptoms and
associated complaints. Higher score represents more symptoms.
As shown in Table 5, the diarrhoea score representing frequency
of stools, loose stools and urgency was significantly higher in
the BP-limb group compared to the A-limb group. The total
GSRS score in the BP-limb group was, however, not signifi-
cantly different from that in the A-limb group (11.1 vs 9.81).
Discussion
The fact that bariatric surgery can fall short of patients’ ex-
pectations is troublesome. Both the amount of initial weight
loss and the risk of later weight regain are issues that need
Table 5 Assessment of symp-
toms by the gastro-intestinal
symptom rating scale (GSRS)
Values given are mean (SD);
p values indicate difference in







GSRS abdominal pain 2.13 (n = 48) 2.01 (n = 57) 0.60
GSRS constipation 2.09 (n = 48) 2.13 (n = 57) 0.90
GSRS diarrhoea 2.66 (n = 48) 1.19 (n = 57) 0.007
GSRS indigestion 2.76 (n = 48) 2.36 (n = 57) 0.14
GSRS reflux 1.45 (n = 48) 1.40 (n = 57) 0.83
Total GSRS score 11.10 9.81
Table 4 Nutritional parameters
outside reference values, number
of patients (%)
Values given are number of pa-
tients and %; p values indicate
difference in prevalence between
the two arms of the study; p<0.05
is taken to indicate statistical
significance
Before surgery 3 to 9 years after surgery (n = 177), median








Albumin 7 (3.7 %) 23 (26.4 %) 18 (20.9 %) 0.394
Vitamin B-12 12 (6.4 %) 24 (26.4 %) 16 (18.6 %) 0.161
Vitamin D 57 (30.5 %) 39 (44.8 %) 18 (20.9 %) <0.001
PTH 1 (0.5 %) 15 (17.2 %) 3 (3.5 %) 0.003
Iron 2 (6.4 %) 32 (36.8 %) 13 (15.1 %) <0.001
Ferritin 11 (5.9 %) 58 (66.7 %) 45 (52.3 %) 0.055
Haemoglobin 2 (1.1 %) 53 (60.9 %) 37 (43.0 %) 0.019
Iron and ferritin 0 (0 %) 20 (23.0 %) 12 (14.0 %) 0.126
Iron and ferritin and haemoglobin 0 (0 %) 15 (17.2 %) 10 (11.6 %) 0.185
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addressing. The mechanisms behind the effect of gastric by-
pass are not yet fully understood. We chose to study the effect
of different limb lengths in a group of consecutive patients,
including both morbidly and super obese.
We found that the longer BP-limb patients did better in
terms of weight loss and showed less weight regain over a 7-
year period. This effect was achieved at the price of more GI
symptoms and a higher need of supplementation.
Why does the 200-cm BP-limb RYGPB results in greater
weight loss than the 150-cm A-limb? When performing
gastric bypass with a 200-cm BP-limb, the whole jejunum
(in most patients) is bypassed and the upper anastomosis is
in fact a gastro-ileal anastomosis. The proposed mechanisms
could be the following: (a) Food directly to the ileum could
affect food tolerance and thereby eating behaviour, and (b)
by creating a 200-cm BP-limb, most of the foregut is
bypassed altering more, or differently, hormonal and immu-
nological factors. We think the main mechanism is probably
the different profile of the GI hormones as demonstrated by
numerous recent studies on metabolic surgery (comment 8,
reviewer 2). (c) In the 200-cm BP-limb group, 50 cm more
of the intestine is bypassed creating consequently a shorter
common channel.
In our database, we have measured the total small intestinal
length in 650 patients to be 620 cm (420–870 cm) (unpub-
lished results). Thus, the common channel in our study will be
more than 3 m in most patients. There is convincing evidence
that the degree of malabsorption after gastric bypass is influ-
enced mainly by the length of the common channel rather than
the lengths of the Roux or biliopancreatic limbs as bypass is
currently constructed by the majority of bariatric surgeons
[16]. Thus, the common channel in our study is probably long
enough to ensure full uptake of calories, so malabsorption of
calories will not explain the difference in weight loss between
the two groups. The tendency of the two curves to converge in
the super obese group should be interpreted with caution as
this is based on few data points. Theremay also be a follow-up
bias favouring those with weight regain problems. Further,
follow-up will reveal whether this tendency will hold.
The metabolic problems associated with biliopancreatic
diversion and very long limb RYGBP are mostly due to the
short common limb [11–15, 23].
We found that 2-m BP-limb is associated with more mi-
cronutrient deficiency than 60-cm BP-limb and 150-cm long
A-limb, especially iron and calcium deficiency, but these
elements are known to be primarily absorbed from the prox-
imal part of the intestines. However, most patients in both
groups needed frequent adjustments of their supplementation
also 5 years or more after surgery, emphasizing the need for
lifelong follow-up after gastric bypass.
Six to 7 years after surgery, gastro-intestinal symptoms
were similar in both study groups; the only significant differ-
ence was more frequent and looser stools in the BP-limb
group. Gastro-intestinal symptoms usually diminish or disap-
pear over time, and differences in symptoms between groups
may have been more pronounced earlier after surgery.
Before this study (in our learning curve), we performed a
gastric bypass with a 2-m BP-limb and a large gastric pouch
(50 ml) [17]; this resulted in high ulcer rate (17 %); the pouch
could dilate and many patient had GI symptoms. By reducing
the pouch to 15 ml and taking good care of the vascularisation
of the major curvature flap, the ulcer rate dropped to 9 %
(same in between groups) and the GI symptoms diminished.
Differences in technique other than limb length (such as
size of gastric pouch or stoma size) may account for weight
loss differences and make it difficult to compare weight loss
results between different studies.
Lee et al. [24] performed loop (mini) gastric bypass with
the BP-limb tailored according to patients’ BMI from 150 to
350 cm and describe a linear relationship between the reduc-
tion in BMI and the BP-limb length. In accordance to our
results, the same group found that a routine use of 2-m BP-
limb mini bypass not only increased weight loss but also
increased the incidence of late nutritional deficiencies, espe-
cially anaemia [25].
We conclude that a gastric bypass with a 2-mBP-limb gives a
better long-term weight loss than gastric bypass with a 150-cm
A-limb, with similar complication rate, but with more nutritional
deficiency. This difference is unlikely due to more malabsorption
but more likely caused by other mechanisms.
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